Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lifecore Set To Go Private Under $239 Million Warburg Pincus Buyout Deal

This article was originally published in The Gray Sheet

Executive Summary

Dental implant maker Lifecore Biomedical is on-track to be acquired by private equity firm Warburg Pincus for $239 million after failing to receive a superior proposal, the firm said Feb. 14

You may also be interested in...



Lifecore Biomedical

Supplier of hyaluronic acid biomaterials for medical applications is acquired by diversified materials science firm Landec Corporation for $40 million up-front, plus assumed debt of $4 million and up to $10 million in future milestone payments. Lifecore Biomedical went private in a 2008 buyout deal with private equity firm Warburg Pincus; Lifecore's dental unit then merged with Warburg Pincus portfolio firm Keystone Dental (1"The Gray Sheet" Feb. 18, 2008)

Lifecore Biomedical

Supplier of hyaluronic acid biomaterials for medical applications is acquired by diversified materials science firm Landec Corporation for $40 million up-front, plus assumed debt of $4 million and up to $10 million in future milestone payments. Lifecore Biomedical went private in a 2008 buyout deal with private equity firm Warburg Pincus; Lifecore's dental unit then merged with Warburg Pincus portfolio firm Keystone Dental (1"The Gray Sheet" Feb. 18, 2008)

Acquisitions In Brief

ConvaTec poised to combine with Unomedical: Ostomy and wound care device business ConvaTec, which is being acquired by private equity firms Nordic Capital Fund VII and Avista Capital Partners from Bristol-Myers Squibb under a May 2 deal, will be combined with Danish single-use medical device maker Unomedical, currently owned by Nordic Capital Fund IV, after the ConvaTec deal closes in the third quarter, the investor groups announce June 27. The combination will enable Unomedical to benefit from Skillman, N.J.-based ConvaTec's "global presence and size," and will continue to be known as ConvaTec, the firms state. ConvaTec has annual sales of $1.15 billion, while Unomedical has revenues of about $418 million, based on current exchange rates. Bristol is sharpening its pharma focus (1"The Gray Sheet" May 5, 2008, In Brief)

UsernamePublicRestriction

Register

MT025787

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel